SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intuition is the L2 for trusted data, and the world's first token-curated graph—allowing people and machines to get the information they need, when they need it, from the sources they trust. With Intuition, you can put your 'intuition' to work—transforming your thoughts, opinions, and experiences into fuel for personalized AI, recommendations, and ads that truly understand you. You fully control your digital identity and data—the most valuable resources of the digital age—enabling you to fully leverage their value while unlocking and democratizing trillions in economic potential. Bring your social graphs, preferences, and 'intuition' with you wherever you go. No more rebuilding your profile and connections from scratch on every new platform—create and curate a universal, portable identity and context that allows applications and AI across the web to understand you instantly. And as you contribute, you’re not just improving your own experience—you’re enhancing the web for everyone who follows and trusts your perspective.

Trust Community Token

Trust Community Token ($TRUST) is trending as traders discuss potential 'round 2' opportunities and consolidation patterns, while also mentioning a prior selloff. The community is actively discussing entry and exit points, with some comparing it to other tokens and suggesting profit-taking strategies in other crypto.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BCRX is trending due to its acquisition of Astria Therapeutics, which aims to strengthen its position in the hereditary angioedema market; however, some investors are expressing concerns about the deal's value and potential impact on shareholder returns. The community is actively debating the long-term implications of this strategic move amidst existing discussions on the company's financial performance and future growth prospects. Short interest remains high as well.

Dogecoin is a cryptocurrency based on the popular "Doge" Internet meme and features a Shiba Inu on its logo. Dogecoin is a Litecoin fork. Introduced as a "joke currency" on 6 December 2013, Dogecoin quickly developed its own online community and reached a capitalization of US$60 million in January 2014. Compared with other cryptocurrencies, Dogecoin had a fast initial coin production schedule: 100 billion coins were in circulation by mid-2015, with an additional 5.256 billion coins every year thereafter. As of 30 June 2015, the 100 billionth Dogecoin had been mined.   Dogecoin was created by Billy Markus from Portland, Oregon and  Jackson Palmer from Sydney, Australia. Both wanted to create a fun cryptocurrency that will appeal beyond the core Bitcoin audience. Dogecoin is primarily used as a tipping system on Reddit and Twitter where users tip each other for creating or sharing good content. The community is very active in organising fundraising activities for deserving causes.  The developers of Dogecoin haven’t made any major changes to the coin since 2015. This means that Dogecoin could get left behind and is why Shibas are leaving Dogecoin to join more advanced platforms like Ethereum. One of Dogecoin strengths is its relaxed and fun-loving community. However, this is also a weakness because other currencies are way more professional.  To purchase Dogecoin, it involves downloading a crypto wallet, setting up a crypto exchange account and then trading away for your desired crypto currency. Once we have set up an account with a DOGE currency exchange and deposited some funds, you are ready to start trading.

Dogecoin

Dogecoin is trending as the community speculates on potential ETF inflows and a possible market rebound. Conversations revolve around identifying the bottom and whether now is the time to buy, while some traders are comparing it to other meme coins. There's also discussion around Dogecoin's potential integration with X payments.

ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. Its products include medical, green energy, and Industrial isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Washington, DC.

ASP Isotopes Inc

ASPI is trending as the community discusses a recently announced private placement in its spin-off, Quantum Leap Energy (QLE), with notable investors including the Trump brothers. This news has sparked excitement about potential catalysts and a broader discussion on the company's prospects in the nuclear and medical isotope industries. Some investors also point to upcoming catalysts including the finalization of the Renergen deal and the QLE spin-off.

Cava Group, Inc. is a holding company, which engages in the category-defining Mediterranean fast-casual restaurant brand, bringing together healthful food and bold, satisfying flavors at scale. It operates through the following segments: CAVA and CAVA Foods. The CAVA segment includes the operations of all company-owned CAVA restaurants. The CAVA Foods segment includes the production of dips and spreads used in CAVA restaurants as well as sales from the consumer-packaged goods (CPG) business. The company was founded by Brett Schulman, Ike Grigoropoulus, Dimitri Moshovitis, and Theodore Xenohristos in 2010 and is headquartered in Washington, DC.

Cava Group Inc

CAVA Group Inc

CAVA is trending amid discussions about its potential bottom and future growth prospects, with some seeing it as a long-term investment, while others express concerns over valuation and broader economic headwinds affecting the restaurant sector. Community members are weighing bullish sentiments against potential short-term challenges and comparing CAVA's performance and positioning relative to competitors like Chipotle. Recent options activity suggests traders are positioning for potential volatility.

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Gilead Sciences, Inc.

Gilead Sciences is trending due to FDA approval of Yeztugo, a twice-yearly injectable for HIV prevention, bolstering its strong HIV portfolio. While the approval is considered an "expected positive," the community is debating the drug's pricing, potential market impact, and how it will influence the company's overall growth amid competition. There is speculation around how insurance coverage and potential cannibalization of existing treatments may affect Gilead's financials.

Grayscale Investments LLC - Grayscale Bitcoin Trust

Grayscale Bitcoin Trust

GBTC is trending as investors weigh its prospects against newer Bitcoin ETFs like IBIT, particularly focusing on expense ratios and management. Community members are actively discussing potential options strategies and near-term price movements for GBTC, as well as comparing it to other crypto-related investment vehicles and Bitcoin itself.

Index Coop is a decentralized autonomous organization (DAO) that builds structured DeFi products and strategy tokens. Index Coop offers a suite of sector index products, leverage and inverse products, and yield-generating products. The product suite runs on Set Protocol, an audited, self-custodial DeFi tool that allows for the creation and management of Ethereum-based (or ERC-20) tokens. Changes to the DAO are voted on by the owners of a governance token called INDEX and then implemented by a team of developers. INDEX holders wield voting power on a 1:1 basis, meaning one token equals one vote.

Index Cooperative

$INDEX is gaining traction as traders discuss its potential for a breakout, citing its low supply and recent product launches in the DeFi space. Community members are weighing in on AI price predictions for 2025, with some suggesting it could skyrocket during altcoin season. Others point to its strong fundamentals and undervalued status, anticipating a significant move upwards.

Tidal Trust II - Defiance Daily Target 2x Long MSTR ETF

Defiance Daily Target 2x Long MSTR ETF

MSTX is trending due to discussions around its leveraged exposure to MicroStrategy (MSTR) and Bitcoin, with traders weighing potential upside from a crypto rally against concerns about contango decay and potential reverse stock splits. Community members are actively debating whether to buy the dip, manage risk with options strategies, or express frustration with the ETF's performance relative to its underlying assets. Bullish sentiment is fueled by anticipation of a Bitcoin breakout and potential S&P 500 inclusion for MSTR.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

Palo Alto Networks is trending as investors weigh its growth prospects against recent developments. Community discussions revolve around its platform strategy, potential AI security advancements, and comparisons to competitors like CrowdStrike. Analyst ratings are mixed, with some highlighting its growth potential and others expressing concerns about valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Kevin Howell

StockTwits for iOS

 Institute of Biomedical Research Ord Shs

Coxnutsandstuff

@Coxnutsandstuff Company isn&#39;t making it easy for us to stay long.

StockTwits For Android 

 Company isn't making it easy for us to stay long.

frank benedetto

@fbenedetto been here over 3 years 🤬. Dumbest trade I have ever done so far.

 been here over 3 years 🤬. Dumbest trade I have ever done so far.

@Coxnutsandstuff I&#39;m hearing there was an initial problem changing transfer agents. He supposedly has this handled and should be moving forward with things now. We will see..but agreed this hasn&#39;t been prolific.

 I'm hearing there was an initial problem changing transfer agents. He supposedly has this handled and should be moving forward with things now. We will see..but agreed this hasn't been prolific.

@fbenedetto it can’t transfer if the stock price is below .01.

 it can’t transfer if the stock price is below .01.

@Coxnutsandstuff he can change transfer agents, he just can&#39;t uplist under 01.

 he can change transfer agents, he just can't uplist under 01.

@fbenedetto is that the news we were supposed to get last week

 is that the news we were supposed to get last week

@Coxnutsandstuff That I don&#39;t know.. I was just made aware of what the underlying issue was. Once the transfer agent issue is resolved he can start implementing all the things he was supposed to have done months ago

 That I don't know.. I was just made aware of what the underlying issue was. Once the transfer agent issue is resolved he can start implementing all the things he was supposed to have done months ago